< Back to previous page
Researcher
Giles Vermeire
- Disciplines:Laboratory medicine, Regenerative medicine, Other basic sciences, Other health sciences, Other medical and health sciences, Medical biotechnology, Drug discovery and development, Pharmaceutics
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Sep 2016 → 7 Dec 2021
Projects
1 - 1 of 1
- Unlocking the potential of intramuscular antibody gene transferFrom1 Sep 2016 → 21 Oct 2021Funding: FWO Strategic Basic Research Grant
Publications
1 - 6 of 6
- UNLOCKING THE POTENTIAL OF PLASMID-BASED ANTIBODY GENE TRANSFER(2021)
Authors: Giles Vermeire, Paul Declerck, Kevin Hollevoet
- Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering(2021)
Authors: Giles Vermeire, Nick Geukens, Paul Declerck, Kevin Hollevoet
Pages: 1200 - 1209 - DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration(2021)
Authors: Giles Vermeire, Nick Geukens, Paul Declerck, Kevin Hollevoet
Pages: 828 - 838 - Building a Versatile and Clinically Translatable Platform for DNA-Based Antibody Therapeutics(2020)
Authors: Kevin Hollevoet, Elien De Smidt, Giles Vermeire, Liesl Jacobs, Stephanie De Vleeschauwer, Nick Geukens, Paul Declerck
Pages: 237 - 238 - Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep(2019)
Authors: Kevin Hollevoet, Stéphanie De Vleeschauwer, Giles Vermeire, Nick Geukens, Paul Declerck
Pages: 1431 - 1443 - Intramuscular Electroporation of DNA-Based Monoclonal Antibodies in Sheep: A Translational Model for Clinical Antibody Gene Transfer(2018)
Authors: Kevin Hollevoet, Stephanie De Vleeschauwer, Elien De Smidt, Giles Vermeire, Nick Geukens, Paul Declerck
Pages: 178 - 179